You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
兄弟科技(002562.SZ):兄弟維生素擬吸收合併大豐製藥
格隆匯 11-22 17:14

格隆匯11月22日丨兄弟科技(002562.SZ)公佈,公司為整合資源,提高子公司的運行效率、提升業績和增強公司整體盈利能力,擬將全資子公司江蘇兄弟維生素有限公司(“兄弟維生素”)與全資子公司大豐兄弟製藥有限公司(“大豐製藥”)實施合併,由全資子公司兄弟維生素為主體吸收合併大豐製藥。合併後,大豐製藥法人資格解散註銷。大豐製藥原有業務、債權債務全部由兄弟維生素承繼,現有員工隨業務全部轉入兄弟維生素。

大豐兄弟製藥有限公司經營範圍:原料藥(硝酸硫胺、維生素B1)製造;藥品技術研發;自營和代理各類商品和技術的進出口業務(國家限定企業經營或禁止進出口的商品和技術除外)。(依法須經批准的項目,經相關部門批准後方可開展經營活動)

兄弟維生素合併大豐製藥的全部資產、負債、權益、業務和人員等;此次合併完成後,兄弟維生素作為合併方存續經營,大豐製藥作為被合併方,其獨立法人資格將被註銷。此次合併完成後,大豐製藥的所有資產、債權債務、業務和人員等一切權利與義務將由兄弟維生素依法承繼。

此次合併,將整合公司資源,提高子公司的運行效率、提升業績和增強公司整體盈利能力。此次合併完成後,大豐製藥的法人資格將被註銷,兄弟維生素將依法承繼其全部資產、負債、權益、業務、人員等。公司合併報表範圍將減少一家法人單位。此次合併對公司的正常經營不會產生重大影響,也不會損害公司及股東權益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account